GENOMIC SCORE TO TARGET THERAPY WITH A FIXED DOSE COMBINATION OF HYDRALAZINE AND ISOSORBIDE DINITRATE

被引：0
|
作者：
McNamara, Dennis M. [1 ]
Feldman, Arthur [1 ]
Yancy, Clyde [1 ]
Taylor, Anne [1 ]
Dries, Daniel [1 ]
Hanley-Yanez, Karen [1 ]
Halder, Indrani [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)31354-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1103-083
引用
收藏
页码：1353 / 1353
页数：1
相关论文
共 50 条
  • [41] Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
    Elizabeth Ofili
    Inder Anand
    Richard Allen Williams
    Ola Akinboboye
    Liou Xu
    Gary Puckrein
    Advances in Therapy, 2017, 34 : 1976 - 1988
  • [42] GNB3 TT genotype predicts enhanced benefit of fixed-dose combination of isosorbide dinitrate and hydralazine in African Americans with heart failure: Results of the A-HeFT trial
    McNamara, Dennis M.
    Tam, S. William
    Sabolinski, Michael L.
    Tobelmann, Page
    Hanley-Yanez, Karen
    Janosko, Karen M.
    Worcel, Manuel
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S71 - S71
  • [43] Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
    Ofili, Elizabeth
    Anand, Inder
    Williams, Richard Allen
    Akinboboye, Ola
    Xu, Liou
    Puckrein, Gary
    ADVANCES IN THERAPY, 2017, 34 (08) : 1976 - 1988
  • [44] Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: Results from A-HeFT
    Cohn, Jay N.
    Tam, William
    Anand, Inder S.
    Taylor, Anne L.
    Sabolfnski, Michael L.
    Worcel, Manuel
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (05) : 331 - 339
  • [45] Beta 1 adrenergic receptor Gly389Arg polymorphism and the impact of fixed-dose combination of isosorbide dinitrate/hydralazine in heart failure: Results from the A-HeFT trial
    McNamara, DM
    Tam, SW
    Sabolinski, ML
    Tobelman, P
    Palmer, A
    Janosko, K
    Feldman, AM
    Worcel, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 67A - 67A
  • [46] Results of the extension to A-HeFT [X-A-HeFT] support the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine (ISDN/HYD)
    Yancy, Clyde W.
    Ghali, Jalal K.
    Braman, Virginia M.
    Sabolinski, Michael L.
    Worcel, Manuel
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S80 - S80
  • [47] POSTURAL HYPOTENSION AND TACHYCARDIA DURING HYDRALAZINE-ISOSORBIDE DINITRATE THERAPY FOR CHRONIC HEART-FAILURE
    MASSIE, B
    KRAMER, B
    HAUGHOM, F
    CIRCULATION, 1981, 63 (03) : 658 - 664
  • [48] LOW USAGE OF HYDRALAZINE AND ISOSORBIDE DINITRATE THERAPY IN ELIGIBLE HEART FAILURE PATIENTS DURING HOSPITALIZATION OR AT DISCHARGE
    Opoku-Asare, Isaac
    Kassim, Thaslim A.
    Napan, Sirikan
    Singh, Steve
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (03) : 629 - 629
  • [49] Usefulness of Isosorbide Dinitrate and Hydralazine as Add-on Therapy in Patients Discharged for Advanced Decompensated Heart Failure
    Mullens, Wilfried
    Abrahams, Zuheir
    Starling, Randall C.
    Young, James B.
    Taylor, David O.
    Tang, W. H. Wilson
    Francis, Gary S.
    Sokos, George
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (08): : 1113 - 1119
  • [50] STUDY REPORTS LOWER MORTALITY WITH HYDRALAZINE ISOSORBIDE DINITRATE THERAPY IN MILD TO MODERATE HEART-FAILURE
    JOHNSON, RS
    CLINICAL PHARMACY, 1986, 5 (07): : 536 - &
12345